Scientists reveal that targeting a pathway in cancer cells that controls the motion of their mitochondria could make them more yielding to radiotherapy.
Scientists reveal that targeting a pathway in cancer cells that controls the motion of their mitochondria could make them more yielding to radiotherapy.
